The probability of acquiring primary Toxoplasma infection in HIV-infected patients: Results of an 8-year retrospective study

Infection

Volumn 26, Issue 1, 1998, Pages 20-25

  Reiter Owona, I ^a   Bialek, R ^b   Rockstroh, J K ^a   Seitz, H M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Institut fur Tropenmedizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHEMOPROPHYLAXIS; CHRONIC PATIENT; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENCEPHALITIS; ENDEMIC DISEASE; FEMALE; FOLLOW UP; GERMANY; HEMOPHILIA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PREVALENCE; PRIMARY INFECTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; SEROCONVERSION; SEROLOGY; STAINING; SURVIVAL; TOXOPLASMA; TOXOPLASMOSIS;

EID: 0031985879     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02768747     Document Type: Article

References (27)

1. Grant, H. I., Gold, W. M., Rosenblum, M., Niedzwiecki, D., Armstrong, D.: Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 4 (1990) 519-521.
2. Pohle, H. D.: Toxoplasmose bei Immunsuppression. In: Pohle, H. D., Remington, J. S. (eds.): Toxoplasmose-Erreger und Krankheit. Socio-medico Verlag, Gräfelfing 1994, pp. 141-164.
3. Montaner, J. S. G., Le Th., Hogg, R., Ricketts, M., Sutherland, D., Strathdee, St. A., O'Shaughnessy, M., Schlechter, M. T.: The changing spectrum of AIDS index diseases in Canada. AIDS 8 (5) (1994) 693-695.
4. RKI-Hefte, AIDS/HIV 1995: Berichte zur epidemiologischen Situation in der Bundesrepublik Deutschland zum 31. 12. 1995. RKI-Heft 13 (1996) 104-105.
5. Ockert, G.: Epidemiologie der Toxoplasmose. In: Shah, W., Stille, W. (eds.): Infektionen durch Toxoplasma gondii. Socio-medico Verlag, Gräfelfing 1991, pp. 19-32.
6. Desmont, G.: Toxoplasmosis in France. Asian J. Clin. Sci. 7 (1987) 89-109.
7. Aspöck, H., Flamm, H., Picher, O.: Die Toxoplasmose-Überwachung während der Schwangerschaft. 10 Jahre Erfahrung in Österreich. Mitt. Österr. Ges. Tropenmed. Parasitol. 8 (1986) 105-113.
8. Kovacs, J. A.: Toxoplasmosis in patients with acquired immunodeficiency syndrome. In: Leoung, G., Mills, J. (eds.): Opportunistic infections in patients with the acquired immunodeficiency syndrome. Marcel Dekker, New York 1989, pp. 343-354.
9. Luft, B. J., Brooks, R. G., Conley, F. K., McCabe, R. E., Remington, J. S.: Toxoplasma encephalitis in patients with acquired immune deficiency syndrome. JAMA 252 (1984) 913-917.
10. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (RR-17) (1992) 1-19.
11. Kamps, B. S., Brodt, H. R., Staszewski, S., Bergmann, L., Helm, E. B.: AIDS-free survival and overall survival in HIV infection. The new CDC classification (1993) for HIV disease and AIDS. Clin. Invest. 72 (1994) 287-292.
12. Sabin, A. B., Feldman, H. A.: Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 108 (1948) 660-663.
13. Zur einheitlichen Laboratoriumsdiagnostik der Toxoplasmose. Empfehlungen für die Durchführung der Toxoplasma-Seroreaktionen. I. Sabin-Feldmann-Test II. Komplementbindungsreaktion. Bundesgesundheitsblatt 23 (1966) 354-357.
14. Saathoff, M., Seitz, H. M.: Untersuchungen von Neugeborenen- und Fetalseren zur Erfassung von konnatalen Toxoplasma-Infektionen. Z. Geburtsh. u. Perinat. 195 (1991) 262-265.
15. Lappallainen, M.: Toxoplasma infection during pregnancy. A prospective cohort study and a cost-benefit analysis. Thesis. Med. Faculty Univ. Helsinki, 1995, p. 20.
16. Enders, G.: Toxoplasmose in der Schwangerschaft. In: Shah, W., Stille, W. (eds): Infektionen durch Toxoplasma gondii. Socio-medico Verlag, Gräfelfing 1991, pp. 33-43.
17. Jacquier, P., Nadal, D., Zuber, P., Eckert, J.: Zur Lage der Infektion mit Toxoplasma gondii bei der schweizerischen Bevölkerung: Beitrag einer seroepidemiologischen Studie aus dem Kanton Zürich. Schweiz. Med. Wochenschr. 125 (Suppl. 65) (1995) 23S-28S.
18. Derouin, F., Thulliez. P., Garin, Y. J.: Interêt et limites de la sérologie de toxoplasmose chez les sujets VIH+. Path. Biol. Paris 39 (1991) 255-259.
19. Gazzinelli, R. T., Sher, A., Cheever, A., Gerstberger, S., Martin, M. A., Dickie, P.: Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo. J. Exp. Med. 183 (1996) 1645-1655.
20. McCabe, R. E., Remington, J. S.: Toxoplasma gondii. In: Mandell, G. L., Douglas, R. G., Bennet, J. E. (eds.): Principle and practice of infectious diseases. Churchill Livingstone Inc., New York 1990, p. 2090.
21. Decoster, A.: Detection of IgA anti-P30 (SAG1) antibodies in acquired and congenital toxoplasmosis. In: Groβ, U. (eds.): Toxoplasma gondii, Springer Verlag, Berlin Heidelberg 1996, pp. 199-205.
22. Pinon, J. M., Foudrinier, F., Mougeot, G., Marx, C., Aubert, D., Toupance, O., Niel, G., Danis, M., Camerlynck, P., Remy, G., Frottier, J., Jolly, D., Bessiers, M. H., Richard-Lenoble, D., Bonhomme, A.: Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients. J. Clin. Microb. 33 (1995) 878-884.
23. Hellerbrand, C., Goebel, F. D., Disko, R.: High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1995) 869-872.
24. Brindle, R., Holliman, R., Gilks, C., Waiyaki, P.: Toxoplasma antibodies in HIV-positive patients from Nairobi. Trans. R. Soc. Trop. Med. Hyg. 85 (1991) 750-751.
25. Luyasu, V., Robert, A. R., Schaefer, L., Macioszek, J., Multicenter Study Group: Multicenter evaluation of a new commercial assay for detection of immunoglobulin M antibodies to Toxoplasma gondii. Eur. J. Microbiol. Infect. Dis. 14 (1995) 787-793.
26. Simmonds, P., Beatson, D., Cuthbert, R., Watson, H., Reynolds, B., Peutherer, J. F., Parry, J. V., Ludlam, C. A., Steel, C. M.: Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 338 (1991) 1159-1163.
27. Ammassari, A., Murri, R., Cingolani, A., De Luca, A., Antinori, A.: AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment. In: Groβ, U. (ed.): Toxoplasma gondii. Springer Verlag, Berlin Heidelberg 1996, pp. 209-220.